Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of Austin 78748, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving Austin 78748 patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving Austin 78748: South Austin Ideal Weight. Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
Tirzepatide seen from Austin 78748, without the jargon. Tirzepatide is often described as the 'next generation' of GLP-1s: a single drug that activates two hormone pathways instead of one.
Beyond the sticker price, look at what is included: consultation, titration, refills, and shipping are sometimes bundled into a single monthly fee. Without insurance coverage, the brand-name price climbs fast; that is what pushes most patients to compare subscription programs that bundle the medication, monitoring, and delivery.
On the cost side, expect about $250-600/month compounded via telehealth; about $1,000-1,400/month brand-name without insurance. depending on the format (brand vs compounded). In this state, Texas Occupations Code §111.001; the reference body is Texas Medical Board. Local landmark: South Austin Ideal Weight (3107 W Slaughter Ln, Austin, TX 78748), rated 5/5 across 2 reviews. Typical dosing: 2.5 - 5 - 7.5 - 10 - 12.5 - 15 mg/week, stepped up by tolerance and goal.
In the SURMOUNT head-to-head trials, tirzepatide produced greater average weight loss, likely thanks to its dual GIP + GLP-1 action. Response is individual and should be assessed by a physician.
Yes: both are tirzepatide. Mounjaro is dosed/labeled for type 2 diabetes, Zepbound for weight management.
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.